c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis.

In a retrospective study the expression of the c-erbB-2 oncogene was determined immunohistochemically in 276 breast cancer samples from 253 patients with the antibody 21N. The follow-up period was between 7 and 12 years. This study showed a trend for an inverse relationship between c-erbB-2 positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeter, C. A., De Potter, C. R., Rathsmann, K., Willighagen, R. G., Greep, J. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977441/
https://www.ncbi.nlm.nih.gov/pubmed/1358163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977441/
https://www.ncbi.nlm.nih.gov/pubmed/1358163

Ejemplares similares